Deutsche Bank
NVCT icon

Deutsche Bank’s Nuvectis Pharma NVCT Stock Holding History

Deutsche Bank’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98K Hold
12,672
– – ﹤0.01% 3288
2025
Q4 		$95.7K Buy
12,672
+12,336
+3,671% +$80.4K ﹤0.01% 3307
2025
Q3 		$2.02K Sell
336
-12,614
-97% -$86.7K ﹤0.01% 3564
2025
Q2 		$96.7K Buy
+12,950
New +$117K ﹤0.01% 3272
2024
Q2 		– Sell
-3,509
Closed -$28.8K – 3654
2024
Q1 		$28.8K Buy
+3,509
New +$29.8K ﹤0.01% 3474

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank's NVCT Position: Q1 2026 in Review

Deutsche Bank held its Nuvectis Pharma (NVCT) position steady in Q1 2026 at 12,672 shares worth $98K. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

Deutsche Bank first reported a position in NVCT in Q1 2024 and has held it in 5 quarters since. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Deutsche Bank held 12,672 shares of Nuvectis Pharma worth $98K as of Q1 2026.
  • Deutsche Bank left its Nuvectis Pharma share count unchanged in Q1 2026.
  • Nuvectis Pharma made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3288 holding.
  • Deutsche Bank first reported a position in Nuvectis Pharma in Q1 2024 and has held it in 5 quarters since.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.